08190142 · Active · incorporated 14 years, 2 months ago · Sandwich
Biotech Biotech & Life Sciences Drug Discovery Series B+
Levicept is a biotechnology company developing novel biological therapies, including LEVI-04, for pain management, particularly in osteoarthritis.
Levicept Ltd is a private limited company registered at Companies House under number 08190142, incorporated on 23 August 2012, with a registered office in Sandwich, Kent. Its current status on the register is active. Its filed nature of business is other professional, scientific and technical activities n.e.c. (SIC 74909). Sonde has indexed 95 filings for this company, including 6 funding rounds. Its most recent round closed in September 2025, raising £2.6m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 6 | Sep 2025 | £2.6m | £58.57 |
| Round 5 | Apr 2024 | £11.1m | £58.57 |
| Round 4 | Nov 2022 | £9.9m | £58.57 |
| Round 3 | Jul 2017 | £3m | £10.00 |
| Round 2 | Oct 2016 | £3m | £10.00 |
| Round 1 | Jan 2015 | €7.5m | €10.00 |
Showing the 10 most recent of 95 filings.
See the complete cap table with every shareholder, founder tags, dilution across 44 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.